NCT06994273

Brief Summary

This study aimed to compare the efficacy and safety of fentanyl versus dexmedetomidine infusion in this population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 29, 2025

Completed
Last Updated

May 29, 2025

Status Verified

May 1, 2025

Enrollment Period

1.5 years

First QC Date

May 19, 2025

Last Update Submit

May 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Weaning eligibility

    The time from ventilator weaning eligibility was monitored until discharge.

    48 hours postoperatively

Secondary Outcomes (3)

  • Time from eligibility to extubation

    60 min postoperatively

  • Mean arterial pressure

    48 hours post-infusion initiation

  • Heart rate

    48 hours post-infusion initiation

Study Arms (2)

Fentanyl group

EXPERIMENTAL

Patients received fentanyl as a 1 μg/kg bolus over 10 min, followed by a 1-5 μg/kg/hr intravenous infusion after 10-15 minutes

Drug: Fentanyl

Dexmedetomidine group

EXPERIMENTAL

Patients received dexmedetomidine as a 1 μg/kg bolus over 10 min, followed by a 0.2-0.7 μg/kg/hr intravenous infusion after 10-15 minutes.

Drug: Dexmedetomidine

Interventions

Patients received fentanyl as a 1 μg/kg bolus over 10 min, followed by a 1-5 μg/kg/hr intravenous infusion after 10-15 minutes.

Fentanyl group

Patients received dexmedetomidine as a 1 μg/kg bolus over 10 min, followed by a 0.2-0.7 μg/kg/hr intravenous infusion after 10-15 minutes.

Dexmedetomidine group

Eligibility Criteria

Age4 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age from 4 to 11 years.
  • Both sexes.
  • Children who required a minimum of 24 hrs of mechanical ventilation following open abdominal surgeries

You may not qualify if:

  • Patients with significant congenital anomalies.
  • Chromosomal abnormalities.
  • Neurologic conditions prohibiting sedation evaluation.
  • Neuromuscular diseases.
  • Those receiving neuromuscular blockers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, El-Gharbia, 31527, Egypt

Location

Related Publications (1)

  • Abotaleb AM, Elsheikh MR, Elshimy KM, AbdelFattah ME. Analgesic and Sedative Effect of Fentanyl Versus Dexmedetomidine Infusion in Postoperative Mechanically Ventilated Children After Open Abdominal Surgeries: Randomized Controlled Trial. Anesthesiol Res Pract. 2025 Jul 3;2025:9699738. doi: 10.1155/anrp/9699738. eCollection 2025.

MeSH Terms

Interventions

FentanylDexmedetomidine

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsImidazolesAzoles

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Study Record Dates

First Submitted

May 19, 2025

First Posted

May 29, 2025

Study Start

April 1, 2023

Primary Completion

October 1, 2024

Study Completion

October 1, 2024

Last Updated

May 29, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations